A prospective dose-controlled interaction between olanzapine and fluvoxamine: Application to pharmacoeconomic optimization of olanzapine treatment in schizophrenia

被引：0
|
作者：
Albers, L
Ozdemir, V
Aravagiri, M
Marder, S
Raggi, M
Reist, C
机构：
[1] VA Long Beach Healthcare Syst, Mental Healthcare Grp, Long Beach, CA USA
[2] Univ Calif Irvine, Long Beach, CA USA
[3] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Univ Bologna, Bologna, Italy
来源：
BIOLOGICAL PSYCHIATRY | 2003年 / 53卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
133
引用
收藏
页码：47S / 48S
页数：2
相关论文
共 50 条
  • [1] Olanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophrenia
    Chaichan, W
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (04) : 364 - 368
  • [2] Standard olanzapine versus placebo and ineffective dose olanzapine in the maintenance treatment of schizophrenia
    Dellva, MA
    Tran, P
    Tollefson, GD
    Wentley, AL
    Beasley, CM
    PSYCHIATRIC SERVICES, 1997, 48 (12) : 1571 - 1577
  • [3] High dose olanzapine in treatment resistant schizophrenia
    Launer, MA
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 149 - 150
  • [4] Reduction in olanzapine therapeutic dosage using a subclinical dose of fluvoxamine in patients with schizophrenia.
    Albers, LJ
    Reist, C
    Ozdemir, V
    Marder, S
    Raggi, MA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P84 - P84
  • [5] Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia
    Chiu, CC
    Lane, HY
    Huang, MC
    Liu, HC
    Jann, MW
    Hon, YY
    Chang, WH
    Lu, ML
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (12): : 1385 - 1390
  • [6] Pharmacoeconomic Assessment of Olanzapine in the Treatment of Refractory Schizophrenia Based on a Pilot Clinical Study
    J. A. Sacristán
    J. C. Gómez
    J. Martín
    E. García-Bernardo
    V. Peralta
    E. Alvarez
    M. Gurpegui
    Clinical Drug Investigation, 1998, 15 : 29 - 35
  • [7] Pharmacoeconomic assessment of olanzapine in the treatment of refractory schizophrenia based on a pilot clinical study
    Sacristan, JA
    Gomez, JC
    Martin, J
    Garcia-Bernardo, E
    Peralta, V
    Alvarez, E
    Gurpegui, M
    CLINICAL DRUG INVESTIGATION, 1998, 15 (01) : 29 - 35
  • [8] Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements - A prospective dose-adjusted drug interaction strategy
    Albers, LJ
    Ozdemir, V
    Marder, SR
    Raggi, MA
    Aravagiri, M
    Endrenyi, L
    Reist, C
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (02) : 170 - 174
  • [9] Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia
    Miyamoto, Setya
    Miyake, Nobumi
    Ogino, Shin
    Endo, Takako
    Yamaguchi, Noboru
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 61 (06) : 702 - 703
  • [10] High dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
    Ermilov, M
    Javitt, DC
    Lichtenberg, P
    Bar, G
    Heresco-Levy, U
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S296 - S297
12345